Classification

 Ehlers-Danlos syndrome type I (EDS1)
 Ehlers-Danlos syndrome type II (EDS2)
 Ehlers-Danlos syndrome type III (EDS3)
 Ehlers-Danlos syndrome type IV (EDS4)
 Ehlers-Danlos syndrome type V (EDS5)
 Ehlers-Danlos syndrome type VI (EDS6)
 Ehlers-Danlos syndrome type VII (EDS7)
 Ehlers-Danlos syndrome type VIII (EDS8)
 Ehlers-Danlos syndrome type IX (EDS9)
 Ehlers-Danlos syndrome with subependymal periventricular heterotopias (EDSSPH) (FLNA mutations) (#7315850#, #15668422#)

Etiology

 haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome (#12865992#)
 mutations in COL1A2 gene

Associations

 pulmonary fibrous pseudotumours (#2076877#)
 pulmonary cysts (#2076877#)

Pathogeny

 All forms of Ehlers-Danlos syndrome (EDS) are associated with abnormalities of collagen. In some forms (e.g., vascular type), there is a mutation in one of the collagen genes, whereas in others (e.g., kyphoscoliosis type), the collagen genes are normal, but there is a mutation in the gene that encodes lysyl hydroxylase, an enzyme essential for the cross-linking of collagen. In these patients, collagen weakness is secondary to a deficiency of lysyl hydroxylase.

See also

 structural protein diseases